ArticleCold Spring Harbor molecular case studies2016

A novel TP53-KPNA3 translocation defines a de novo treatment-resistant clone in osteosarcoma.

Kenneth S Chen et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.